Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce A Sutcliffe

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
JAMA Surgery|November 17, 2016
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical TrialJoseph Solomkin, David Evans, Algirdas Slepavicius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapyJay C Butler, Jeffrey L Lennox, Linda K McDougal, et al.
Journal of Medicinal Chemistry|February 10, 2011
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agentsRoger B Clark, Minsheng He, Corey Fyfe, et al.
Journal of Medicinal Chemistry|March 2, 2017
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosaYonghong Deng, Cuixiang Sun, Diana K Hunt, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infectionsJoseph S Solomkin, Mayakonda Krishnamurthy Ramesh, Gintaras Cesnauskas, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibioticTrudy H Grossman, Agata L Starosta, Corey Fyfe, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in GermanyRalf R Reinert, Rudolf Lütticken, Joyce A Sutcliffe, et al.
The Journal of Antibiotics|July 27, 2017
Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogensCuixiang Sun, Yonghong Deng, Diana K Hunt, et al.
The Journal of Antibiotics|March 29, 2002
A novel antibiotic CJ-17,572 from a fungus, Pezicula spYutaka Sugie, Koen A Dekker, Taisuke Inagaki, et al.
Journal of Medicinal Chemistry|May 1, 2015
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial AgentsCuixiang Sun, Diana K Hunt, Chi-Li Chen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
JAMA Surgery|November 17, 2016
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical TrialJoseph Solomkin, David Evans, Algirdas Slepavicius, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Macrolide-resistant pneumococcal endocarditis and epidural abscess that develop during erythromycin therapyJay C Butler, Jeffrey L Lennox, Linda K McDougal, et al.
Journal of Medicinal Chemistry|February 10, 2011
8-Azatetracyclines: synthesis and evaluation of a novel class of tetracycline antibacterial agentsRoger B Clark, Minsheng He, Corey Fyfe, et al.
Journal of Medicinal Chemistry|March 2, 2017
Heterocyclyl Tetracyclines. 1. 7-Trifluoromethyl-8-Pyrrolidinyltetracyclines: Potent, Broad Spectrum Antibacterial Agents with Enhanced Activity against Pseudomonas aeruginosaYonghong Deng, Cuixiang Sun, Diana K Hunt, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
Phase 2, randomized, double-blind study of the efficacy and safety of two dose regimens of eravacycline versus ertapenem for adult community-acquired complicated intra-abdominal infectionsJoseph S Solomkin, Mayakonda Krishnamurthy Ramesh, Gintaras Cesnauskas, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2012
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibioticTrudy H Grossman, Agata L Starosta, Corey Fyfe, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in GermanyRalf R Reinert, Rudolf Lütticken, Joyce A Sutcliffe, et al.
The Journal of Antibiotics|July 27, 2017
Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogensCuixiang Sun, Yonghong Deng, Diana K Hunt, et al.
The Journal of Antibiotics|March 29, 2002
A novel antibiotic CJ-17,572 from a fungus, Pezicula spYutaka Sugie, Koen A Dekker, Taisuke Inagaki, et al.
Journal of Medicinal Chemistry|May 1, 2015
Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial AgentsCuixiang Sun, Diana K Hunt, Chi-Li Chen, et al.
Pageof 3